Inhibitors of mitochondrial fission
AssigneeQueen's University at Kingston
InventorsDanchen Wu, Michael Wells, Stephen Archer
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions that include inhibitors of mitochondrial fission are described for the treatment and/or mitigation of cancer, pulmonary arterial hypertension, cardioprotection, stroke, coronary heart disease, neurological disorder, a neurodegenerative disease, Parksinonism, Huntington's Chorea, Alzheimer's disease, diabetic cardiomyopathy, fatty liver diseases, non-alcoholic fatty liver diseases, or alcohol-related liver disease.
Claims7
A method for reducing or inhibiting mitochondrial fission, wherein the mitochondrial fission is associated with pulmonary arterial hypertension, comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising:
Dependencies are inferred from the claim text.